Joseph Fredi

October 27, 2016

Trial to test aortic valve technique in lower-risk patients

In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.

By Jessica Pasley
Heart illustration
April 18, 2011

Vanderbilt Heart to participate in CoreValve clinical trial

Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart’s aortic valve.

By Kathy Whitney